by MM360 Staff | Aug 23, 2025 | Uncategorized
Source: CureToday articles Multiple myeloma is a chronic blood cancer affecting plasma cells, but with today’s treatments many patients can manage symptoms and live fulfilling lives. Read More
by MM360 Staff | Aug 21, 2025 | Uncategorized
Source: CureToday articles The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form. Read More
by MM360 Staff | Aug 15, 2025 | Uncategorized
Source: CureToday articles Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly 30 years. Read More
by MM360 Staff | Aug 13, 2025 | Uncategorized
Source: CureToday articles Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, along with potent new CELMoD drugs, all offering more targeted and effective options for patients. Read...
by MM360 Staff | Aug 12, 2025 | Uncategorized
Source: CureToday articles Ashley Dieks and Dr. Saad Z. Usmani discussed how bicycling may help patients cope with the emotional and physical challenges of their myeloma diagnosis. Read More
by MM360 Staff | Aug 1, 2025 | Uncategorized
Source: CureToday articles SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for relapsed/refractory multiple myeloma. Read More
